Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 400

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 11
Chunk 400
---
Includes
                                            healthcare benefits and 401(k) contribution of $4,286 and $0, respectively, for
                                            the fiscal year ended December 31, 2023.

(5)Includes
                                            healthcare benefits and 401(k) contribution of $0 and $0, respectively, for
                                            the fiscal year ended December 31, 2024.

(6)During
                                            2023, Mr. Elmasri, through his consulting company, Titan Advisory Services, LLC (“Titan”) agreed to defer all salary compensation and to reduce his salary to $250,000
                                            beginning on February 1, 2023, and further reduced to $60,000 beginning on October 1, 2023.
                                            The deferred compensation is recorded in accrued compensation as of December 31, 2023. No
                                            interest was accrued or due on the deferred compensation for 2023. Mr. Elmasri and his wife are the only shareholders of Titan.

On
September 29, 2023, Mr. Elmasri, on behalf of Titan, agreed to forgive $164,720 of earned compensation in exchange for 81,599 options to purchase common stock,
49,417 restricted stock units, and $45,000 to be paid out as a bonus upon an IPO. The options to purchase common stock have a strike
price of $1.33. On December 18, 2023, the restricted stock units issued on September 29, 2023 were cancelled and reissued as part of
an additional forgiveness, whereby Mr. Elmasri agreed to forgive the $45,000 of accrued bonus in exchange for 22,320 options to purchase
common stock and an additional 16,875 restricted stock units (total of 66,292 restricted stock units). The options to purchase common
stock have a strike price of $1.33.

(7)Includes
                                            healthcare benefits and 401(k) contribution of $0 and $0, respectively, for
                                            the fiscal year ended December 31, 2023.

(8)Includes
                                            healthcare benefits and 401(k) contribution of $0 and $0, respectively, for
                                            the fiscal year ended December 31, 2024.

(9)During
                                            2023, Mr. Hayward agreed to defer all salary compensation and to reduce his salary to $67,200
                                            beginning on October 1, 2023. The deferred compensation is recorded in accrued